Search Results - "Peng, Shirong"

SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion by Li, Zean, Tao, Yiran, Gao, Ze, Peng, Shirong, Lai, Yiming, Li, Kaiwen, Chen, Xu, Huang, Hai

“…Metastatic prostate cancer (mPCa) has a poor prognosis with limited treatment options. The high mobility of tumor cells is the key driving characteristic of…”
Get full text

The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma by Tang, Jingxia, Peng, Shirong, Yan, Haifeng, Ni, Ming, Hou, Xiaodan, Ma, Peizhi, Li, Yuanlong

“…•AKIP1 was higher in GBM vs. LGG tissues, and in GBM cell lines vs. control cell line.•AKIP1 promoted GBM cell invasion, CD133+ proportion, and sphere…”
Get full text

Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer by Wang, Qiong, Li, Zean, Yang, Jin, Peng, Shirong, Zhou, Qianghua, Yao, Kai, Cai, Wenli, Xie, Zhongqiu, Qin, Fujun, Li, Hui, Chen, Xu, Li, Kaiwen, Huang, Hai

“…OBJECTIVETo explore the genetic changes in the progression of castration-resistant prostate cancer (CRPC) and neuroendocrine prostate cancer (NEPC) and the…”
Get full text

Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study by Chen, Peixian, Wang, Yue, Xiong, Zhi, Luo, Tianlong, Lai, Yiming, Zhong, Haitao, Peng, Shirong, Zhuang, Ruilin, Li, Kaiwen, Huang, Hai

“…Although many epidemiological studies and meta-analyses have reported an association between autoimmune disorders and prostate cancer, none has reported a…”
Get full text

B7 score and T cell infiltration stratify immune status in prostate cancer by Zhou, Qianghua, Li, Kaiwen, Lai, Yiming, Yao, Kai, Wang, Qiong, Zhan, Xiangyu, Peng, Shirong, Cai, Wenli, Yao, Wei, Zang, Xingxing, Xu, Kewei, Huang, Jian, Huang, Hai

“…BackgroundAlthough immune checkpoint inhibitors (ICIs), especially programmed cell death protein 1 (PD-1)/programmed death ligand 1 (PD-L1) axis blockers,…”
Get full text

Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancer by Peng, Shirong, Zhang, Xinyu, Huang, Hao, Cheng, Bisheng, Xiong, Zhi, Du, Tao, Wu, Jun, Huang, Hai

“…Prostate cancer (PCa) is the second most common malignant tumor among males. Traditional treatments for PCa, which include surgery and endocrine therapy, have…”
Get full text

Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer by Gao, Ze, Tao, Yiran, Lai, Yiming, Wang, Qiong, Li, Zean, Peng, Shirong, Chen, Junxiu, Cai, Wenli, Li, Kaiwen, Huang, Hai

“…Immune checkpoint inhibitors (ICIs) treatment is becoming a new hope for cancer treatment. However, most prostate cancer (PCa) patients do not benefit from it…”
Get full text

The metastatic promoter DEPDC1B induces epithelial‐mesenchymal transition and promotes prostate cancer cell proliferation via Rac1‐PAK1 signaling by Li, Zean, Wang, Qiong, Peng, Shirong, Yao, Kai, Chen, Junxiu, Tao, Yiran, Gao, Ze, Wang, Fen, Li, Hui, Cai, Wenli, Lai, Yiming, Li, Kaiwen, Chen, Xu, Huang, Hai

“…Metastasis is the major cause of prostate cancer (PCa)‐related mortality. Epithelial‐mesenchymal transition (EMT) is a vital characteristic feature that…”
Get full text

GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer by Wang, Qiong, Wu, Wanhua, Gao, Ze, Li, Kaiwen, Peng, Shirong, Fan, Huiyang, Xie, Zhongqiu, Guo, Zhenghui, Huang, Hai

“…Chemoresistance is the major cause of death in advanced prostate cancer (PCa), especially in metastatic PCa (mPCa). However, the molecular mechanisms…”
Get full text

Immune Signatures Combined With BRCA1-Associated Protein 1 Mutations Predict Prognosis and Immunotherapy Efficacy in Clear Cell Renal Cell Carcinoma by Gao, Ze, Chen, Junxiu, Tao, Yiran, Wang, Qiong, Peng, Shirong, Yu, Shunli, Zeng, Jianwen, Li, Kaiwen, Xie, Zhongqiu, Huang, Hai

“…Immunotherapy is gradually emerging in the field of tumor treatment. However, because of the complexity of the tumor microenvironment (TME), some patients…”
Get full text

MP05-01 CHOLESTEROL METABOLISM REPROGRAMMING INDUCES THE SECRETION OF MDK TO PROMOTE M2 POLARIZATION OF MACROPHAGES AND PROMOTES THE PROGRESSION OF PROSTATE CANCER by Huang, Hai, Peng, ShiRong

Get full text

Fuzheng–Buyi formula for treating castration-resistant prostate cancer: A systematic review and meta-analysis by Liang, Xiao, Peng, Shirong, Huang, Hai, Xu, Jia, Liu, Wenjuan, Wang, Hailong, Li, Qi

“…The study was designed to systematically evaluate the efficacy and safety of Fuzheng-Buyi formula in treating castration-resistant prostate cancer…”
Get full text

Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer by Li, Bingheng, Cheng, Bisheng, Huang, Hao, Huang, Shanhe, Yu, Shunli, Li, Zean, Peng, Shirong, Du, Tao, Xie, Ruihui, Huang, Hai

“…Darolutamide, an androgen receptor inhibitor, has been approved by the Food and Drug Administration (FDA) for the treatment of prostate cancer (PCa),…”
Get full text

MT1G, an emerging ferroptosis‐related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer by Cheng, Bisheng, Lai, Yiming, Huang, Hao, Peng, Shirong, Tang, Chen, Chen, Junxiu, Luo, Tianlong, Wu, Jilin, He, Haixia, Wang, Qiong, Huang, Hai

“…Background Prostate cancer is a leading cause of cancer‐related deaths in men worldwide. Despite advances in treatment strategies, there is still a need for…”
Get full text

Evaluating the effectiveness of cytoreductive surgery in oligometastatic prostate cancer: insights from quantitative analysis and retrospective cohort studies by Cheng, Bisheng, Li, Bingheng, Fu, Jianhan, Wang, Qiong, Luo, Tianlong, Li, Zean, Peng, Shirong, Wu, Jilin, Zhou, Qianghua, Wu, Peng, Huang, Hai

“…Oligometastatic prostate cancer (OmPCa) is characterized by a restricted number of metastatic lesions confined to a limited organ range, presenting a distinct…”
Get full text

Sorafenib Encapsulated Poly(ester amide) Nanoparticles for Efficient and Biosafe Prostate Cancer Therapy by Yu, Shunli, Zhang, Ruhe, Xie, Zhaoxiang, Xiong, Zhi, Peng, Shirong, Li, Bingheng, Zhuang, Ruilin, Wu, Jun, Huang, Hai

“…Prostate cancer (PCa) with a high incidence worldwide is a serious threat to men’s health. Despite the continuous development of treatment strategies for PCa…”
Get full text

Topoisomerase II-binding protein 1 promotes the progression of prostate cancer via ATR-CHK1 signaling pathway by Li, Kaiwen, Peng, Shirong, Li, Zean, Lai, Yiming, Wang, Qiong, Tao, Yiran, Wu, Wanhua, Zhou, Qianghua, Gao, Ze, Chen, Junxiu, Li, Hui, Cai, Wenli, Guo, Zhenghui, Huang, Hai

“…DNA damage response (DDR) plays an important role in the progression of cancers, including prostate cancer (PCa). Topoisomerase II-binding protein 1 (TopBP1)…”
Get full text

Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methods by Li, Kaiwen, Li, Zean, Tao, Yiran, Wang, Qiong, Lai, Yiming, Wu, Wanhua, Peng, Shirong, Guo, Zhenghui, Huang, Hai

“…P38α plays a crucial role in the development of castration-resistant prostate cancer. Discovering novel inhibitors of P38α offers potential for the development…”
Get full text

A ferrite sphere Y-junction waveguide circulator by Dengguo, Zhang, Shirong, Peng, Futiang, Huang

“…A novel 4-mm waveguide circulator with a ferrite sphere is presented. The operation modes and frequency splits of the circulator are also discussed, and…”
Get full text